chrisvoncsefalvay/vaers-outcomes huggingface dataset:
His Adam's apple area is very swollen; currently in the hospital without the ability to swallow/not able to swallow; Does he have to start over from scratch with the second vaccine dose since it has ben over 6 weeks from the first?/it has been over 42 days; Does he have to start over from scratch with the second vaccine dose since it has ben over 6 weeks from the first?"/He received the second dose, 4 days ago, on 19uly2021; doctors think he has an infection, his lungs have pneumonia; his lungs are full; This is a spontaneous report from a contactable consumer (patient's spouse). An 82-years-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number EW0181), via an unspecified route of administration on 19Jul2021 (82-years-old at the time of vaccination) as single dose for COVID-19 immunization. Medical history included Tested positive for COVID-19 on 05Mar2021, after receiving the first dose of the vaccine on 07Feb2021 (Lot# EN5818). The patient's concomitant medications were not reported. The patient previously took bnt162b2 for COVID-19 immunisation and experienced High temperature (hospitalized from 05Mar2021 to 07Apr2021), No taste or smell -all events were reported as resolved. Patient's wife reported that her 82 years spouse who received his first vaccine on 07Feb2021 and who then tested positive for Covid on 05Mar2021 (also reported he had COVID in Apr2021), had been hospitalized twice with a high fever. Patient wife told it has been over 42 days, that's why the delay in the second vaccine dose, weren't sure if they should get one or not, so does he start all over again or does he just take the second shot? She states she has asked every medical person in town and no one knows, so she is calling the source. As of 23Jul2021 it was further reported that the patient received his second vaccine shot on Sunday [19Jul2021] and 2 days later [21Jul2021] he was not able to swallow. His Adam's apple area was very swollen since 21Jul2021 and he was being in the hospital for 4 days due to swollen Adam's apple, with inability to swallow. He was in emergency for several days and he was getting worse. The patient was currently in hospital. The doctors put their heads together and they can't figure out what is wrong with him; the reporter think's it's a reaction to the vaccine. The doctors think "he has an infection, his lungs have pneumonia, his lungs are full".   No follow-up attempts are needed; information about lot/batch number cannot be obtained.  Follow-up (23Jul2021): New information reported from the same contactable consumer (patient's wife) includes: additional events "inability to swallow", "Adam's apple area is very swollen", "Infection / his lungs have pneumonia", "his lungs are full", all assessed as serious, second vaccine dose date and Lot#. Case upgraded to serious.   Follow-up attempts are completed. No further information is expected.
Fever, aches, chills, headache followed by pain and swelling at injection site. Phantosmia has not gone away. Smelling phantom cigarette smoke.
Swelling of glands, felt rapidly sick, itchy throat, swelling of throat. Took two Benadryl and swelling gradually went down. Took a third Benadryl two hours later.
Pain at injection site starting 6 hours after injection, persisting for at least 1 day Headache starting at 20 hours after injection, persisting for at least  1 day
Starting 11/05/2022, I developed chest pain and a 102 fever. I ran a home EKG and was in afib. My heart rate was running 128-148. I went to the ER and my BP was so low that they were very concerned and couldn't believe it. They transported me to a specialty hospital via ambulance. They determined I had an effusion caused by an unknown virus. They tested for all COVID-19 and Flu Variants but all were negative. I am still in afib and still have an effusion. However, they are having me wait it out to see if it goes down on its own then they can give me blood thinner prophylactically to prevent stroke. Per the hospital, they could neither confirm nor deny that the vaccine may have played a part.
Rash all over (scalp, face, neck, chest, back, arms, legs, feet).  Only palms and soles of feet did not have spots.  Decreased appetite.  Irritability.  Trouble sleeping.  No fever.
This case was reported by a healthcare professional and described the occurrence of itch all over in a 37-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). On 1 October 2013 the subject received a dose of FLUARIX (.5 ml, unknown route, right arm). On 2 October 2013, 1 day after vaccination with FLUARIX, the subject experienced itch all over and hives all over. At the time of reporting the events were unresolved. The healthcare professional considered the events were probably related to vaccination with FLUARIX. Follow-up was received on 09 October 2013. The nurse practitioner documented that the subject was 37 years old not 67 years old as previously documented in the report. The nurse practitioner further documented that the events were partly at the injection site but "it was pretty much all over." Follow-up information was received on 06 November 2013 via healthcare professional who reported the events occurred on 02 October "2014" and resolved on 10 October "2014", although the reporter may have intended the current year of "2013". The reporting healthcare professional did not consider the event serious. No action was taken with FLUARIX.
This spontaneous report as received form a physician via a company representative refers to a 14 year old female patient. On 17-JUN-2014 the patient was vaccinated with the first dose of GARDASIL (lot#, strength, dose, frequency, route unspecified). No concomitant medications were taken. The patient became dizzy five minutes after the dose was given. The physician stated that the patient did not faint. The physician stated that the patient laid down and was given ginger ale, and recovered soon after (on 17-JUN-2014. No treatment was given for AE. This is one of several reports received from the same source. Additional information has been requested.
Few hours after administration, pt felt arm in inflamed, burning spreaded from arm to neck and shoulder blades and arms. Seek medical attention from her physician. Doctor diagnosed her with Brachial Plexus Neuritis. Taking anti-inflammatory.
Patient reports headaches that come & go. Her arm where she received vaccine is broken out in round red bumps which itch.
Information has been received from a physician and a healthcare worker concerning a 50 year old female with sulfa and amoxicillin (+) clavulanate potassium allergies who on 9/27/05 was vaccinated SC in the left arm with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot # 650453/0791P). On 9/29/05, the patient presented to the physician's office with a right upper extremity that was red, warm, and patchy. The healthcare worker noted a discrepancy in the documentation because the client was vaccinated in the left arm, but the adverse event was documented in the right arm. The patient was treated with a methylprednisolone dose pack. No diagnostic laboratory tests were performed. The physician requested a lot check. Results are pending. Right upper extremity that was red, warm and patchy was considered to be an other important medical event by the reporter (OMIC). Additional information has been requested.
Vaccination that had expired; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 6-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number 74FN7, expiry date 1st March 2021) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 6th October 2021, the patient received Pediarix. On an unknown date, the patient started Pediarix Pre-Filled Syringe Device. On 6th October 2021, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: This case was reported via chat with Practice manager. On 6th October 2021, the patient received a dose of a Pediarix which was already expired on 1st March 2021. The reporter asked that what was the procedure to fix this error. The reporter consented to follow up via email.
patient was administered 0.3ml of pfizer bivalent 5-11years with out diluted. no adverse reaction or side effects noted
The patient awoke the following morning after the vaccine and encountered a swollen left eye, including tissues around the eye.
I only had soreness of the arm as a side effect/felt the soreness in the site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administered in arm, administration date 23Feb2021 (Lot number: EM9810) at the age of 66 years as dose 1, single and administered in arm, administration date 16Mar2021 (Lot number: EM6207) as dose 2, single for covid-19 immunisation. Relevant medical history included: "severe asthma" (ongoing), notes: patient with a history of asthma. There were no concomitant medications. Vaccination history included: Flu (Manufacturer: Fluzone High Dose 2122PF influenza split high dose preservative free 65+ Lot Number: UJ743AC , right arm, she had 0.7 mL, IM LD), administration date: 06Oct2021, when the patient was 65 years old.  The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "I only had soreness of the arm as a side effect/felt the soreness in the site".  Additional information: this report was not related to a study or program.  Follow-up attempts are completed. No further information is expected.
IPV rt thigh reaction. Lt thigh 32 cm. Rt thigh 34 cm.
Headache, Myalgia, NauseaVomiting, Localized itching; chills, fatigue, Narrative:  Other Relevant History:
Rash, hives, difficulty breathing. Face, arms, neck legs, abdomen, back.
Patient called office today stating that she feels nausea, vomiting, fever and abdominal pain since Tuesday, September 10th.
Fever, severe chills, shakes, couldn?t get my bones warm. Side effects lasted for 36 hours, also had extreme fatigue for the following week
Right deltoid muscle ache began within 1 hour after injection and resolved within 24 hours. Muscle and joint pain in entire body began on 6/2/2021 at about 3 a.m. and resolved on 6/3/2021 at about 8 a.m. Headache, chills, fever, and a dry cough began on 6/2/2021 at 4 a.m. The fever fluctuated between 99.5 degrees F and 101.3 degrees F. The chills and fever resolved on 6/2/2021 at 10 p.m. The headache resolved on 6/3/2021 at 10 a.m. The headache was frontal type pain in the forehead with sensitivity to light. The dry cough is still ongoing right now on 6/4/2021 at approximately 6:15 a.m. It is a dry, non-productive cough, worse during the day and less at night.
Pt presented to ER via EMS at 1556  3 days after receiving vaccine. pt was breathing approximately 50 times a minutes and o2 sats in the 70's upon arrival. NP decided to intubate, Rocuronium and Versed given. Pt became bradycardic and 1 amp of Atropine was given without improvement. No pulse felt, CPR started per ACLS protocol. 7 Epi's given. Time of death- 1632. After TOD pt was swabbed for COVID-19 and the results were positive.
The patient developed a rash across her right abdomen, side, and around her back. She went to the dr after coming to show us at the pharmacy on 2/18/15 to confirm our diagnosis of shingles and receive treatment. I spoke with her as a follow-up on 2/21/15. She is in terrible pain and wishes she didn't get the vaccine.
This spontaneous report as received from a 70 years old male patient refers to himself with high blood pressure. The patient had no drug reactions/allergies. On 01-OCT-2013 the patient was vaccinated with a dose of ZOSTAVAX (Lot# unspecified) dose, route and location unspecified and an influenza virus vaccine (unspecified) (Lot# U8908AA, expiry date: 30-JUN-2014, Sanofi Pharmaceuticals) at the same time, and developed "numbness" in both of his feet after receiving these two vaccines. The patient reported that the numbness in his feet happened "immediately" after receiving the two vaccines, "at the same time on the same exact day". The patient stated "certain days my feet feel like I am walking with broken bones and the numbness is always there". The patient then reported that the numbness would go into the "ankle" area and half way up into his knees. The reporter stated that he felt like he was "walking on nails". The reporter also stated that he had experienced the numbness in his hands. The patient then stated that within the last 4 or 5 days (estimated in January 2014), the bottoms of his feet are "red hot". The patient also stated he was using many other "unspecified medications" (names/dosage/frequencies/manufacturers unspecified). The patient stated that he was not recovered and now he was using a "cane" to help him walk. The patient had sought medical attention via saw the doctor. Upon internal review, using a "cane" to help him walk was considered as disability. Additional information has been requested.
AE: Diaphoretic, nervous, dizzy( at 4:01pm) Treatment: no medication was given. patient was under observation.  Outcome: symptoms resolved with observation and patient was sent to POV/Home.
2 hrs p/vax taken to ER hives all over body-eyes, face, scrotum, eyes swollen, face puffy, breathing OK;
Several children, ages 6-16, vax w/ booster dose;  complained of stinging at inject site.  Stinging lasted for 1 minute.
Developed Postural Tachycardia Syndrome (POTS) with vomiting and diarrhea, 20 lb weight loss. She was evaluated by pedi GI, who made the diagnosis based on labs, EKG, vital signs, and clinical presentation.  Symptoms started 3 days after the 2nd Pfizer COVID vaccination was administered. She was treated with supportive care (fluids, salt, compression stockings), omeprazole 20 mg BID, cyproheptadine 2 mg BID. She received a single dose of decadron (for croup on June 25,2021). Her symptoms have improved though they have not fully resolved. she continues on omeprazole and cyproheptadine.
6 scattered varicella vesicles on an erythemic base were noted on pt trunk;
Patient vaccinated x4 (Moderna: 3/20/21, 4/17/21, 8/17/21, 2/14/22)  Patient hospitalized and tested positive for COVID on 5/29/22
Chills, headache neck and shoulder ache, naoses and could not get out of bed, no treatment, took a couple of Tylenols. I have a virtual appt. with my internist today regarding it.
she woke up and felt weak; difficulty breathing; light headedness (dizzy); some loss of feeling in feet; little soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (she woke up and felt weak), DYSPNOEA (difficulty breathing), DIZZINESS (light headedness (dizzy)), HYPOAESTHESIA (some loss of feeling in feet) and VACCINATION SITE PAIN (little soreness at the injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (little soreness at the injection site). On 02-Feb-2021, the patient experienced ASTHENIA (she woke up and felt weak), DYSPNOEA (difficulty breathing), DIZZINESS (light headedness (dizzy)) and HYPOAESTHESIA (some loss of feeling in feet). At the time of the report, ASTHENIA (she woke up and felt weak), DYSPNOEA (difficulty breathing), DIZZINESS (light headedness (dizzy)) and HYPOAESTHESIA (some loss of feeling in feet) outcome was unknown and VACCINATION SITE PAIN (little soreness at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
This spontaneous report was received from a 73 years old male patient who was referring to himself. The patient did not have any drug reactions or allergies. The patient's medical history included herpes zoster on an unknown date (reported as "in [his] 30s"). On an unknown date in 2015 (reported as about two years ago), the patient was vaccinated with ZOSTAVAX injection (dose, lot # and expiry date were not provided). Concomitant therapies included tamsulosin hydrochloride and atorvastatin. On an unknown date in 2017 (reported as "just recently"), the patient developed shingles. Unspecified treatment was given for the event. The outcome of shingles was reported as not recovered. The causality assessment was not provided.
patient received vaccination, and he was with his father, he was fine , then he left , he said he went to sit down , he fell, I did not see it.
Presents with inner aspect (L) upper arm fiery red, non-tender, not indurated. No nodes felt (L) axillary. Cellulitis, aseptic. No Rx.
Narrative:  PATIENT PASSED AWAY DUE TO COVID-19 . HE HAD RECEIVED A COVID-19 VACCINE.
Client began itching/scratching her nose, behind ears and upper chest immediately (within 1 minute after injections). Requested client stay until 1:55 for monitoring. Gave IM BENADRYL 25 mg (R) deltoid at 1:15. Never developed any hives, laryngeal or oral edema. No difficulty breathing. Left facility with mother carrying her at 1:55. Advised ER if any worsening or recurrence.
Pt had syncope, put cold rags on neck and gave him some water.  About 15 minutes he was fine.
slightly sore arm; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 15Mar2021 at 12:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis. Concomitant medication included paracetamol(TYLENOL), CBD salve (MANUFACTURER UNKNOWN), biotin vitamin (MANUFACTURER UNKNOWN) and moringa tea (MANUFACTURER UNKNOWN)) from unknown date for unspecified indication. The Patient did not have any allergies to medications, food, or other products, but can't take ibuprofen. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the Patient had not tested for COVID-19. On, 15Mar2021 the patient experienced tiredness and slightly sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the tiredness and slightly sore arm was resolved on unknown date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a nurse concerning a patient who was vaccinated with VARIVAX (Oka/Merck) (therapy started date, route, site unknown) developed breakthrough chicken pox over a year after the second dose.  Patient's medical history and drug reactions/allergies were unspecified by reporter.  The patient's case of chicken pox was mild less than 50 lesions and sought medical attention.  At the time of report patient had recovered.   This is one of several reports received from the same source.  Additional information has been requested.
A report has been received from a Physician concerning a Child, Female subject, who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started during Sep-2014. The patient experienced MD AND HER CHILDREN RECEIVED FLUMIST AND THEN TESTED POSITIVE INFLUENZA which started during Dec-2014. The patient recovered from the event of MD AND HER CHILDREN RECEIVED FLUMIST AND THEN TESTED POSITIVE INFLUENZA on an unspecified date. The report was considered to be non-serious.
Information has been received from a licensed practical nurse via concerning a female patient who on an unspecified date was vaccinated with the first dose of GARDASIL. Concomitant therapy included generic form of ORTHO TRI-CYCLEN. Shortly after receiving the vaccination, the patient was losing all of her body hair. Unspecified medical attention had been sought. The action taken and the status of the patient were unknown. This is one of several reports received from the same source. Follow-up information was received from the nurse. She reported that it was an acquaintance of one of her patients whose daughter had the experience. Additional information is not expected.
Patient received MMRV, Varicella, Flu and PCV13 on 1/26/2021 for his 1 year well child check. Mother/guardian is being notified and health department is being  contacted, safety net is being filed  with facility.
One month after 1st Administration 6/12/17-Pt developed tremors in hands that continued. Also developed a few headaches. One month after 2nd 6/27/18 pt had a gran mal seizure. Severe headaches, photosensitivity, sensitivity to flashing lights.
Patient experienced ongoing and severe/disabling low blood sugar for several hours. We could not get her blood sugar to stabilize at home and had to take her to the emergency room for assistance.
Rt arm swelling around inject site occurred 1 hr p/inject given; bruising, swelling area approx 5-6 cm in size; area tender & sore reddened & bruised on outside of induration;
1st dose on 21Jun2021, 2nd not received; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix on 21st June 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 07-OCT-2022 Reporter's Comment: The patient had not received 2nd dose of Shingrix yet. The vaccine administration facility was the same as primary reporter. The healthcare professional ended chat before answering if follow up was ok. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The VAERS details were provided for 1st dose of Shingrix.
Autism/encephalopathy. Starting only since vaccine. Severe rash. Dx given by MD. Follow up states pt did not recover. Encephalopathy, autism. Large gross delays in language, auditory processing, social interaction, immunological development, G I absorption. Also very strange behaviors that are involuntary (such as banging head) occur virtually constantly. Pt may not have been a good candidate for 3 vaccines to be given at one time because he might've had a poorly developed immune system and may have been fighting an earlier infection.